CRWD vs DHR: Which Is the Better Buy?
Side-by-side comparison of CrowdStrike Holdings, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
CrowdStrike Holdings, Inc. · Technology
$259.67
-13.1% upside to fair value
Low Conviction
Grade C
High Quality
VS
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWD |
DHR |
| Current Price |
$259.67 |
$221.12 |
| Fair Value Estimate |
$225.56 |
$286.52 |
| Upside to Fair Value |
-13.1%
|
+29.6%
|
| Market Cap |
$264.4B |
$155.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
595.7x
|
24.8x
|
| Price / Sales |
49.0x
|
6.2x
|
| Price / FCF |
167.9x
|
28.5x
|
| Revenue Growth YoY |
+25.8%
|
+5.5%
|
| Gross Margin |
75.2%
|
58.5%
|
| Operating Margin |
-2.2%
|
20.4%
|
| Return on Equity |
1.3%
|
7.7%
|
| Dividend Yield |
0% |
0.65% |
| FCF Yield |
0.6%
|
3.51%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
CrowdStrike Holdings is a cloud-native cybersecurity platform company that sells subscriptions to its Falcon platform and a growing array of cloud modules spanning endpoint protection, cloud workload security, identity protection, Next-Gen SIEM, threat intelligence, and managed services, generating revenue through a direct sales force and channel partners from its Austin, Texas headquarters with …
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Accumulation Zones
| Metric |
CRWD |
DHR |
| Zone Low |
$169.17 |
$214.89 |
| Zone High |
$191.73 |
$243.54 |
| In Buy Zone? |
No
|
Yes
|